NOVAVAX INC (NVAX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for NOVAVAX INC (NVAX): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 48/100 — a percentile rank of NOVAVAX INC’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.
| Market cap | $1.7B |
| P / S | 4.2× |
| EV / EBITDA | -15.7× |
| Gross margin | 78.6% |
| Operating margin | -56.6% |
| Net margin | -59.9% |
| Return on equity | 129.9% |
| ROIC | 278.7% |
| Revenue growth | -61.6% |
| Debt / equity | -1.6× |
| Dividend yield | 0.0% |
Is NOVAVAX INC overvalued? P/S looks overvalued vs its 5-year range.
Independent of the events above — derived from NOVAVAX INC’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact